The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients

Intensive Care Medicine

Volumn 26, Issue 10, 2000, Pages 1566-1570

  Fronhoffs, Stefan ^a   Luyken, Joachim ^a   Steuer, Kurt ^b   Hansis, Martin ^b   Vetter, Hans ^a   Walger, Peter ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

C1 esterase inhibitor; Capillary leak syndrome; Necrotizing fasciitis; Streptococcal toxic shock syndrome

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CLINDAMYCIN; COMPLEMENT COMPONENT C1S INHIBITOR; GENTAMICIN; IMMUNOGLOBULIN; NORADRENALIN; PIPERACILLIN; TAZOBACTAM;

ADULT; AGED; ARTICLE; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG EDEMA; MALE; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

EID: 0033791945     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000654     Document Type: Article

References (10)

1. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition
2. Role of superantigens in human disease
3. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2
4. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation
5. C1-Esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema
6. The flesh-eating bacterium: What's next?
7. Invasive group A streptococcus infections
8. Proteolytic inactivation of plasma C1-inhibitor in sepsis
9. C1-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro
10. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome